These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25329225)

  • 21. Usefulness of lymphocyte activation test in atorvastatin hypersensitivity.
    Piñero Saavedra MC; Prados Castaño M; Sánchez B; Lucena Soto JM; Avila Castellanos R; Ortega-Camarero M
    J Investig Allergol Clin Immunol; 2011; 21(7):574-5. PubMed ID: 22312946
    [No Abstract]   [Full Text] [Related]  

  • 22. Atorvastatin-induced diaphragmatic muscle impairment.
    Sulem P; Bagheri H; Faixo Y; Montastruc JL
    Ann Pharmacother; 2001 Oct; 35(10):1292-3. PubMed ID: 11675865
    [No Abstract]   [Full Text] [Related]  

  • 23. Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies.
    Minha S; Golzman G; Adar I; Rapoport M
    Isr Med Assoc J; 2009 Jul; 11(7):440-1. PubMed ID: 19911499
    [No Abstract]   [Full Text] [Related]  

  • 24. Myopathy after switching from brand to generic atorvastatin.
    Awoniyi O; Gosmanov AR
    J Am Geriatr Soc; 2013 Dec; 61(12):2254-2255. PubMed ID: 24329838
    [No Abstract]   [Full Text] [Related]  

  • 25. Intensive lipid lowering with atorvastatin in coronary disease.
    Ravnskov U; Rosch PJ; Sutter MC
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834
    [No Abstract]   [Full Text] [Related]  

  • 26. High-dose statins and the IDEAL study.
    Ravnskov U; Rosch PJ; Sutter MC
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757714
    [No Abstract]   [Full Text] [Related]  

  • 27. High-dose statins and the IDEAL study.
    Ong HT; Cheah JS
    JAMA; 2006 Jun; 295(21):2476-7; author reply 2478-9. PubMed ID: 16757712
    [No Abstract]   [Full Text] [Related]  

  • 28. High-dose statins and the IDEAL study.
    Cayley WE
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757713
    [No Abstract]   [Full Text] [Related]  

  • 29. Atorvastatin-clopidogrel interaction.
    Martin PT; Denman R
    Circulation; 2003 Jun; 107(24):e223; author reply e223. PubMed ID: 12821599
    [No Abstract]   [Full Text] [Related]  

  • 30. Comment and reply on: Atorvastatin: safety and tolerability. Statins and polymyositis: a neglected link?
    Famularo G; Minisola G; Gasbarrone L
    Expert Opin Drug Saf; 2010 Nov; 9(6):1005-6; author reply 1006. PubMed ID: 20919802
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
    Golomb B; Evans M
    Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
    [No Abstract]   [Full Text] [Related]  

  • 32. Atorvastatin-induced hemorrhagic cystitis: a case report.
    Martinez-Suarez HJ; Wang R; Faerber GJ
    Urology; 2009 Mar; 73(3):681.e5-6. PubMed ID: 18468659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute cholestatic hepatitis after atorvastatin reintroduction].
    de Castro ML; Hermo JA; Baz A; de Luaces C; Pérez R; Clofent J
    Gastroenterol Hepatol; 2006 Jan; 29(1):21-4. PubMed ID: 16393626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
    Cannon CS
    JAAPA; 2012 Aug; 25(8):30, 32-3. PubMed ID: 22928274
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypothyroidism misdiagnosed as statin intolerance.
    Krieger EV; Knopp RH
    Ann Intern Med; 2009 Jul; 151(1):72. PubMed ID: 19581652
    [No Abstract]   [Full Text] [Related]  

  • 36. Fixed drug eruption due to atorvastatin.
    Huertas AJ; Ramírez-Hernández M; Mérida-Fernández C; Chica-Marchal A; Pajarón-Fernández M J ; Carreño-Rojo A
    J Investig Allergol Clin Immunol; 2015; 25(2):155-6. PubMed ID: 25997318
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
    Newman C; Tsai J; Szarek M; Luo D; Gibson E
    Am J Cardiol; 2006 Jan; 97(1):61-7. PubMed ID: 16377285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune hepatitis revealed by atorvastatin.
    Pelli N; Setti M; Ceppa P; Toncini C; Indiveri F
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):921-4. PubMed ID: 12867804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
    Marusic S; Lisicic A; Horvatic I; Bacic-Vrca V; Bozina N
    Int J Clin Pharm; 2012 Dec; 34(6):825-7. PubMed ID: 23076661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
    Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E
    Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.